May 23, 2025

Strategic moves that secure prime properties

Master property negotiation with expert strategies that build confidence and enhance your competitive edge, ensuring you secure the right asset at the right terms...

Urban Logistics REIT Plc declares 4.35p interim dividend

Urban Logistics REIT Plc announces a 4.35 pence interim dividend for H2 FY 2025, boosting total annual dividends to 7.60 pence per share...

Patria Private Equity Trust Plc posts April NAV of 784p

Patria Private Equity Trust plc reports its estimated net asset value (NAV) at 784.0 pence per share for April 2025, alongside dividend details and investment activities...

Games Workshop Group Plc expects record £255m PBT for FY2025

Games Workshop Group Plc forecasts strong financial growth for 2025, with core revenue hitting £560 million. Discover key insights on profits and dividends...

GSK Plc Nucala approved by FDA for Eosinophilic COPD

GSK's Nucala (mepolizumab) gains FDA approval as a crucial add-on treatment for adults with inadequately controlled COPD and eosinophilic phenotype...

HUTCHMED showcases new oncology data at ASCO 2025

HUTCHMED (China) Limited is set to unveil groundbreaking data on key cancer therapies at the 2025 ASCO Annual Meeting, highlighting promising advancements in NSCLC and solid tumors...
Search

Funds

May 23, 2025

Strategic moves that secure prime properties

Master property negotiation with expert strategies that build confidence and enhance your competitive edge, ensuring you secure the right asset at the right terms...

Urban Logistics REIT Plc declares 4.35p interim dividend

Urban Logistics REIT Plc announces a 4.35 pence interim dividend for H2 FY 2025, boosting total annual dividends to 7.60 pence per share...

Patria Private Equity Trust Plc posts April NAV of 784p

Patria Private Equity Trust plc reports its estimated net asset value (NAV) at 784.0 pence per share for April 2025, alongside dividend details and investment activities...

Games Workshop Group Plc expects record £255m PBT for FY2025

Games Workshop Group Plc forecasts strong financial growth for 2025, with core revenue hitting £560 million. Discover key insights on profits and dividends...

GSK Plc Nucala approved by FDA for Eosinophilic COPD

GSK's Nucala (mepolizumab) gains FDA approval as a crucial add-on treatment for adults with inadequately controlled COPD and eosinophilic phenotype...

HUTCHMED showcases new oncology data at ASCO 2025

HUTCHMED (China) Limited is set to unveil groundbreaking data on key cancer therapies at the 2025 ASCO Annual Meeting, highlighting promising advancements in NSCLC and solid tumors...
Search

Funds

May 23, 2025

FTSE 100

Funds